Biotechnology sector ETFs were among the best performers Tuesday, with Illumina (NasdaqGS: ILMN) shares surging after the genomics firm beat second-quarter expectations and raised its year-end outlook.

Among the best performing ETFs of Tuesday, the Invesco Dynamic Biotech & Genome (NYSEArca:PBE) increased 3.0%, ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG) advanced 2.5% and iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB) rose 2.0%.

Meanwhile, ILMN shares jumped 11.2% Monday. ILMN makes up 4.8% of PBE, 7.6% of ARKG and 5.2% of IBB.

Evercore analyst Ross Muken said in that the Illumina stock story is “far too compelling to ignore,” reports Allison Gatlin for Investor’s Business Daily.

“The breadth/scope of portfolio strength in this quarter was truly remarkable,” Muken said in a report. “We haven’t barely even scratched the surface on many areas driving the notable inflection (such as oncology).”

Subscribe to our free daily newsletters!
Please enter your email address to subscribe to ETF Trends' newsletters featuring latest news and educational events.